| 000 | 00000nam##2200000za#4500 |
| 001 | 9.559966 |
| 003 | CaOODSP |
| 005 | 20210624173132 |
| 007 | cr ||||||||||| |
| 008 | 150406|2005||||xxc|||||o f|0| 0 eng|d |
| 020 | |a0-662-42136-1 |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH81-1/1-2005E-PDF |
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
| 245 | 14|aThe impact upon public drug plans of changes in drug distribution |h[electronic resource] |
| 260 | |bPatented Medicine Prices Review Board |cNovember 2005. |
| 300 | |a24p.|bfig., graphs, references, tables |
| 490 | 1 |aNational Prescription Drug Utilization Information System - analytical study series |
| 500 | |aThe catalogue number (H81-1/1-2005) and ISBN (0-662-69492-9) for the bilingual print edition have been incorrectly copied in this electronic publication. |
| 590 | |a12-01-Supp|b2012-01-13 |
| 690 | 07|aPrescription drugs|2gcpds |
| 775 | 08|tIncidence des nouvelles formules de distribution des médicaments d'ordonnance sur les budgets des régimes publics d'assurance-médicaments |w(CaOODSP)9.592677 |
| 830 | #0|aNational Prescription Drug Utilization Information System - analytical study series.|w(CaOODSP)9.504983 |
| 856 | 40|ahttp://publications.gc.ca|qPDF|s438 KB|uhttps://publications.gc.ca/collections/collection_2011/cepmb-pmprb/H81-1-1-2005-eng.pdf |